Ayala Pharmaceuticals, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year One in USD from Q3 2019 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Ayala Pharmaceuticals, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year One history and growth rate from Q3 2019 to Q4 2023.
  • Ayala Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One for the quarter ending December 31, 2023 was $171K.
Lessee, Operating Lease, Liability, to be Paid, Year One, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year One, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $171K Dec 31, 2023 10-K 2024-04-16
Q3 2023 $380K Sep 30, 2023 10-Q 2023-11-20
Q2 2023 $380K +$367K +2823% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $345K +$332K +2554% Mar 31, 2023 10-Q 2023-05-23
Q2 2022 $13K Jul 31, 2022 10-Q 2022-09-13
Q1 2022 $13K Apr 30, 2022 10-Q 2022-06-08
Q4 2021 $13K -$1.38M -99.1% Jan 31, 2022 10-Q 2022-03-17
Q3 2021 $29K -$1.29M -97.8% Oct 31, 2021 10-K 2022-02-14
Q4 2020 $1.4M Jan 31, 2021 10-Q 2021-03-16
Q3 2020 $1.32M +$85K +6.89% Oct 31, 2020 10-K 2021-01-22
Q2 2020 $1.32M Jul 31, 2020 10-Q 2020-09-10
Q3 2019 $1.23M Oct 31, 2019 10-K 2019-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.